1. Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients
Kim et al. Am J Nephrol 2016;44:71-80 (DOI: / )
Table 1: Patient clinical characteristics

2. Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients
Kim et al. Am J Nephrol 2016;44:71-80 (DOI: / )
Table 2: Patient clinical characteristics based on the group before and after PSM

3. Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients
Kim et al. Am J Nephrol 2016;44:71-80 (DOI: / )
Fig. 1: Number of interventions of recurrent group patients. The median duration of the first intervention after the first successful cannulation was 4.5 months (interquartile range months). The number of interventions the 71 patients underwent in the recurrent group is shown. The minimum and the maximum number of interventions were 2 and 13, respectively. Most patients had 2 or 3 incidents of interventions; 21 patients (29.6%) had more than 5 such incidents. Three patients had more than 10 instances of interventions, and the highest number of intervention was 13. Of the 295 total interventions, 263 (89.2%) were PTA. PTA = Percutaneous transluminal angioplasty.

4. Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients
Kim et al. Am J Nephrol 2016;44:71-80 (DOI: / )
Table 3: Follow-up duration and outcomes before and after PSM

5. Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients
Kim et al. Am J Nephrol 2016;44:71-80 (DOI: / )
Table 4: Parameters included in the predictive equation for outcomes estimated by using Cox proportional hazards model

6. Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients
Kim et al. Am J Nephrol 2016;44:71-80 (DOI: / )
Fig. 2: CV event-free survival based on the group before and after PSM. a Before PSM, patients in the recurrent group had lower CV events-free survival (p = 0.004). b After PSM, CV event-free survival of the recurrent group was still significantly lower than that in the non-recurrent group (p = 0.001). Analyzed by using Cox proportional hazards model, adjusted for age, sex, DM, hypertension, dyslipidemia, underlying CV disease, VA type and corrected Ca. CV = Cardiovascular; DM = diabetes mellitus; VA = vascular access; Ca = calcium.

7. Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients
Kim et al. Am J Nephrol 2016;44:71-80 (DOI: / )
Fig. 3: Composite ACM or CV event-free survival according to group before and after PSM. a Before PSM, patients in the recurrent group had lower ACM/CV event-free survival (p = 0.003). bAfter PSM, composite ACM/CV event-free survival of the recurrent group was still significantly lower than in the non-recurrent group (p = 0.007). Analyzed by Cox proportional hazards model, adjusted for age, sex, DM, hypertension, dyslipidemia, underlying CV disease, VA type and corrected Ca. CV = Cardiovascular; DM = diabetes mellitus; VA = vascular access; Ca = calcium.